Photoisomerization of Sulindac and Ozagrel Hydrochloride by Vitamin B 2 Catalyst Under Visible Light Irradiation.

or FAD under excessive light exposure should be avoided as a caution during intravenous administration of sulindac or ozagrel hydrochloride.